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1. Introduction 
A variety of agents such as urea [ 11, SDS [2-51 
and alkali [6-91 bring about a progressive, polar 
disassembly of TMV. Frequently, a series of more or 
less stable, intermediate-length particles can be 
observed uring the stripping of the virus [lo] . Con- 
trary to [4,11] both alkali [9] and SDS [S] strip 
TMV from the 5’- to the 3’ end of the viral RNA. 
DMSO strips TMV from the 3’- to the 5’-end of the 
RNA [ 121 ; the coat protein gene was thus assigned to 
within 2000 nucleotides of the 3’end of TMV RNA 
[ 131. Since the initial assumption required to make 
this assignment, namely that viral assembly isa polar 
process [141 beginning at the S’end of the RNA 
[15-181,isnowknowntobewrong [19,20],it 
seemed important o reinvestigate he polarity of 
stripping in DMSO and to consider its implications 
for the location of the coat protein gene. 
The results presented in this paper suggest that at 
least the principal direction of uncoating in DMSO is 
from the 5’- to the 3’-terminus of the RNA. 
2. Materials and methods 
TMV vulgare strain, was a generous gift from P. J. 
G. Butler, MRC Lab. Molec. Biol. Cambridge. The 
virus was stored at a concentration of 30 mg/ml at 
Abbreviations: TMV, tobacco mosaic virus, DMSO- 
dimethylsulphoxide; SDS, sodium dodecyl sulphate; EDTA, 
ethylenediaminetetra-acetic acid;EGTA, ethyleneglycol-bis- 
(2-aminoethyl ether) N,N’-tetraacetic a id 
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4°C in sodium phosphate buffer, pH 7.0, ionic strength 
0.05-0.10 mol/l. 
2.1. Treatment of TMV with DMSO 
TMV suspension, 10 ml, 2.5 mg/ml, in 0.01 M 
phosphate buffer, pH 7.0, was added to 115 ml 
water-DMSO solution to give final cont. 72% 
DMSO (by vol.). Incubation was carried out at 24°C 
for 30 min. The procedure followed [ 121 except hat 
the exposed RNA tails were removed with micrococcal 
nuclease (EC 3.1.4.7; Boehringer) in the presence of 
1 mM calcium chloride [5,9] . No bentonite was 
required, the nuclease activity was terminated by 
adding EGTA (neutralized with KOH) to final cont. 
5 mM. The protected RNA-fragments were then 
extracted by the standard 2-phase phenol procedure 
in the presence of SDS (0.5-l .O%, w/v) and EDTA 
(5-10 mM) as recommended [21]. The extracted 
RNA was precipitated with 75% ethanol/50 mM 
NaCl at -20°C for several hours. It was harvested in 
an MSE 18 refrigerated centrifuge at 10 000 rev/min 
for 20 min at -5°C. The pellets of RNA were washed 
with fresh ethanol/NaCl and taken up in a small volume 
of buffer (100 mM NaCl, 1 mM EDTA, 10 mM Tris- 
HCl, pH 7.5,0.1% SDS). The total RNA extract was 
then fractionated by sucrose density-gradient cen- 
trifugation on linear 10-40%, w/v, diethylpyro- 
carbonate-treated [22] sucrose density gradients 
(6.5 ml). The gradients were made up with the same 
buffer except hat 0.1% SDS was omitted from the 
40% sucrose solution. The gradients were spun at 
50 000 rev/min for 3.5 h at 15°C in an MSE 
Superspeed 65 ultracentrifuge. The contents of each 
tube were fractionated by pumping out from the 
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bottom through a canula and the RNA peaks were mobility. Using this technique to calibrate the sucrose 
located by following the Aam. The RNA fragments density centrifugation, the average molecular weights 
were precipitated once again with ethanol/NaCl and of the RNA fragments comprising fractions (1) and 
the pellets resuspended in water to give final RNA (2) in fig.1 were estimated. The results are shown in 
cont. 1 PM (see section 3). table 1. 
A control preparation of TMV RNA was prepared 
simultaneously, following an identical procedure but 
omitting DMSO. 
Species of TMV RNA that contain the intact 
3’terminal nucleotide sequence CpCpCpA-OH 
found in the viral RNA can be charged with histidine 
in the presence of yeast histidyl-tRNA synthetase 
[ 5,9,24] . The ability of the various RNA species in 
fractions (1) and (2) (fig.1) and control, 27 S, RNA 
to be charged with histidine was therefore tested. 
The results are shown in table 1. It is reassuring to 
note first that the control, 27 S, RNA from intact 
rods obtained in the absence and presence of DMSO 
have almost identical specific radioactivities in the 
charging assay. The RNA which occurs in the same 
position of the gradient as fractions (1) and (2) in 
the absence of a stripping agent arises by adventitious 
shearing of the viral rods, presumably during handling 
[5] . Thus these RNA fragments have a specific 
histidine-acceptor activity which is almost exactly 
half that of control, 27 S, RNA [5] . From the results 
in table 1, it appears that the enhanced numbers of 
RNA fragments in fractions (1) and (2) following 
DMSO-treatment, possess intact, functional 3’- 
terminal sequences in approx. 80% and 60% of cases, 
respectively. It would therefore seem reasonable to 
conclude that the effect of 72% (by vol.) DMSO upon 
intact TMV rods is to cause disassembly predominant- 
2.2. Histidineucceptor abilities 
The ability of TMV RNA fragments to form amino- 
acyl derivatives with [3H]histidine (55 mCi/E.tmol; 
The Radiochemical Centre, Amersham, Bucks) in the 
presence of yeast aminoacyl-tRNA synthetases was 
tested exactly as in [9] . 
3. Results and discussion 
A typical separation by sucrose density-gradient 
centrifugation of the TMV RNA fragments produced 
by the DMSO-stripping procedure described above is 
shown in fig.1. The sedimentation coefficient of 
intact TMV RNA is 27 S, corresponding with mol. wt 
2.2 X lo6 [23] . The disassembly of TMV at alkaline 
pH produces a series of defined nucleoprotein frag- 
ments [lo] . The pieces of RNA obtained from these 
intermediates can be analysed by sucrose density- 
gradient centrifugation, in which case a straight-line 
graph is obtained by plotting log (mol. wt) versus 
SEDIMENTATION > 
0.6 
1 
0.4 
0.2 
Fig.1. Sucrose density gradient centrifugation (lo-40% sucrose) of the RNA extracted from TMV (vulgare strain) in the 
presence (+) or absence (-) of DMSO (720/o, by vol.). Samples, 0.25 ml, were collected. The exposed RNA tails were removed 
from partly stripped rods by treatment with micrococcal nuclease before the RNA was extracted. For other details, see the text. 
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Table 1 
RNA source Mol. wt Cont. 
(PM) 
Histidine-acceptor activity 
(cpm [ 3H]histidine/pmol RNA) 
Control (+tRNA) 
No activating 
enzymes 
2.5 x lo6 20 63 
Total E. coli tRNA 
27 S TMV RNA (-DMSO) 
27 S TMV RNA (+DMSO) 
Fraction (1) (+DMSO) 
Fraction (2) (+DMSO) 
2.5 x 10’ 20 3950a 
2.2 x lo6 1 4000 
2.2 x 106 1 4200 
0.9 x lo6 1 3310 
0.1-0.2 x lo6 l-2 2480b 
a Assuming tRNAhis = 0.05 mol/mol total tRNA 
b Average specific acceptor activity 
The various species of RNA were incubated at the stated concentrations for 30 min at 30°C with 
[3H]histidine and the aminoacyl-tRNA synthetase system [9,24]. Control incubations without 
any added RNA gave approx. 500 cpm [‘HI histidine 
ly, if not exclusively at first, from the 5’-end of the 
viral RNA. After stripping has proceeded from the 
5’-end for some distance [ 121, it may then commence 
from the 3’-terminus, resulting in the two-tailed rods 
[ 121 which occur under extreme stripping conditions 
(72% DMSO or above). The RNA from such particles 
would be unable to bind histidine, hence the reduced 
ability for aminoacylation among the shorter RNA 
fragments. 
From the incorporation of radiolabelled histidine, 
it can be calculated that the 27 S RNA species (and 
E. coli tRNAhis, assuming it to represent 0.05 mol/ 
mol total tRNA) have average acceptor act. 0.25 mol 
histidine/mol RNA. For comparison, 0.5 mol/mol 
was obtained with intact TMV RNA and fragments 
produced by disassembly in SDS [5], and 0.32-0.37 
mol/mol obtained with intact TMV RNA and frag- 
ments produced in alkali [9,25]. The present decrease 
in histidine-binding efficiency may reflect the age of 
the aminoacyl-tRNA synthetase preparation. 
It would appear therefore, that DMSO, in common 
with other stripping agents, brings about a polar 
disassembly of TMV which begins at the 5’4erminus 
of the intact viral RNA. 
Fingerprint analysis [26] of the fragments of RNA 
obtained by partial stripping in alkali [9] , located the 
coat protein gene in the 3’4erminal 1000 nucleotides 
of TMV RNA. The location of the coat protein gene 
in the 3’4erminal2000 nucleotides [ 131 is consistent 
with this despite a wrong assumption as to the direc- 
tion of virus self-assembly from the 5’-end [15-l 81 
and consequently, about the direction of DMSO 
stripping [ 121. The coat protein gene was located 
[ 131 by screening for specific encapsidation with 
coat protein of RNA fragments prepared by mild Tl 
ribonuclease treatment of the RNA tails exposed 
either by partial stripping in DMSO or during limited 
reconstitution of the virus. We now know that self- 
assembly proceeds initially from an internal point on 
the RNA, to the left [ 191 of the coat protein gene, 
predominantly in the 5’-direction [20,27,28]. The 
inconsistencies implicit in these studies from various 
laboratories can therefore be resolved by recognizing 
that partially reconstituted virus particles may still 
possess an exposed coat protein cistron which, after 
mild Tl ribonuclease digestion, would give rise to the 
RNA fragments specifically encapsidated by coat 
protein. There is no doubt therefore, that the coat 
protein gene is located in the 3’4erminal 1000 nucleo- 
tides of the viral RNA. 
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